# Study of Metatinib Tromethamine Tablet

> **NCT02650375** · PHASE1 · UNKNOWN · sponsor: **Jiangsu Simcere Pharmaceutical Co., Ltd.** · enrollment: 24 (estimated)

## Conditions studied

- Advanced or Metastatic Gastric Cancer
- Advanced or Metastatic Liver Cancer
- Advanced or Metastatic CRC
- Advanced or Metastatic Non Squamous NSCLC

## Interventions

- **DRUG:** Metatinib Tromethamine

## Key facts

- **NCT ID:** NCT02650375
- **Lead sponsor:** Jiangsu Simcere Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2017-10
- **Final completion:** 2018-02
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2017-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02650375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02650375, "Study of Metatinib Tromethamine Tablet". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02650375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*